Genmab’s American Depositary Receipt (ADR) Program
Genmab established a sponsored Level 3 ADR program with Deutsche Bank Trust Company Americas. An ADS represents ownership of shares in a non-US corporation. ADSs issued under Genmab's ADR Program are quoted and traded in US dollars on the Nasdaq Global Select Market in the United States. Ten Genmab ADSs correspond to one Genmab ordinary share.
Click here to access Genmab's ADS details on Deutsche Bank's website.
ADR ticker symbol: GMAB
Structure: Level 3 ADS
Exchange: Nasdaq Global Select Market
Ratio: 10 ADRs : 1 ordinary share
DR ISIN : US3723032062
CUSIP: 372303 206
Contact details for ADS investors and brokers:
Deutsche Bank ADS broker services desks
New York: +1 212 250 9100
London: +44 207 547 6500
Contact details for registered ADS Holders:
Deutsche Bank Shareholder Services
6201 15th Avenue
Brooklyn, NY 11219
Toll-free: +1 866 706 0509
Toll: +1 718 921 8137
American Depository Shares (“ADSs”) are U.S. dollar-denominated negotiable instruments represented by American Depositary Receipts (“ADRs”) issued by a depositary bank that facilitate U.S. trading and investment in shares of non-U.S. companies.
The Nasdaq Global Select Market is a segment of the Nasdaq Stock Exchange in the United States that lists shares of select companies that meet its most stringent financial and liquidity requirements, as well as its corporate governance standards.
Converting ordinary shares into ADSs must be done through a broker investment advisor or for registered holders through Deutsche Bank Trust Company Americas. You can contact Deutsche Bank broker services desk on +1 212 250 9100 or +44 207 547 6500.
If you do not hold ADSs via a broker, bank or nominee, please contact Deutsche Bank at the contact details listed above.
Historical share prices for Genmab’s ADSs can be found on the stock information page.
Genmab does not currently pay dividends to holders of ordinary Genmab shares or ADR shares.